Blogs & Articles
Showing 13–24 of 28 results
Information on compound-target engagement obtained from traditional in vitro binding assays differs greatly from that in a physiologically relevant model…
Read MoreCellular membrane proteins play important functions in many biological processes. Understanding their roles often requires that these proteins be isolated…
Read MoreAs newer, cutting-edge therapeutic technologies emerge, an increasing need for rapid and reliable screening tools follows.
Read MoreThe COVID-19 pandemic has left us racing against time for remediation. As a result, we have witnessed hundreds of therapeutic…
Read MoreImportance in Drug Discovery & Development for Quality Testing Programs. GPCR CNR1 Bioassay example.
Read MoreTherapeutic antibodies that can elicit different applications of cell-mediated cytotoxicity, such as Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) and many other effector…
Read MoreCytokines and their receptors have emerged as major drug targets for inflammatory and autoimmune diseases, allergies, and, more recently, in…
Read MoreEurofins DiscoverX, in conjunction with Drug Target Review, sponsored and moderated a Bioassay roundtable discussion webinar with group leaders from…
Read MoreA novel and growing modality in drug discovery has been the application of Targeted Protein Degradation (TPD). TPD involves the…
Read MoreGlucagon-Like Peptide-1 (GLP-1), a member of the glucagon-secretin peptide family, is secreted from L-cells of the small intestine and binds…
Read MoreDrugs interact with living physiology; an in vitro assay of drug activity can be considered a snapshot of the full…
Read MoreGPCRs have long been regarded as a low-hanging fruit drug target as they are conveniently located on the cell surface…
Read More